PIP : Summary for PharmAthene, Inc - Yahoo Finance

U.S. Markets closed

PharmAthene, Inc. (PIP)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.78-0.00 (-0.60%)
At close: 4:01PM EDT
People also watch
OCRXPULMSIGAPLXCERU
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.79
Open0.78
Bid0.00 x
Ask0.00 x
Day's Range0.75 - 0.81
52 Week Range0.47 - 3.50
Volume524,709
Avg. Volume4,786,491
Market Cap53.7M
Beta2.22
PE Ratio (TTM)0.26
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PharmAthene, Inc. :PIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube5 days ago

    PharmAthene, Inc. :PIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis PharmAthene, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of PharmAthene, Inc. – Emergent BioSolutions Inc., Pfizer Inc., Dynavax Technologies Corporation, Baxter International Inc., Cempra, Inc., Johnson & Johnson, XOMA Corporation and SIGA Technologies Inc (EBS-US, PFE-US, DVAX-US, BAX-US, ... Read more (Read more...)

  • PR Newswire12 days ago

    PharmAthene Reports Year-End 2016 Financial and Operational Results

    ANNAPOLIS, Md., March 14, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results ...

  • PR Newswire13 days ago

    PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction with Altimmune

    ANNAPOLIS, Md., March 13, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, announced today that it has established a record date and meeting date for a special meeting of stockholders to vote upon, among other things, the proposal to adopt the agreement and plan of merger and reorganization involving PharmAthene and Altimmune, Inc. PharmAthene stockholders of record at the close of business on March 22, 2017, will be entitled to receive the notice of, and to vote at, the PharmAthene special meeting. The PharmAthene special meeting will be held on May 4, 2017.